Dermatology News

 
 
  • AAD Clinical Trial Brings Hope for Prurigo Nodularis Patients Serlopitant is the first treatment shown to be effective for patients with this uncommon disorder, which is characterized by crusty lesions and intense itch.
  • Immediate Reconstruction After Mastectomy Becoming More Common in Elderly Women Among elderly women, rates of immediate breast reconstruction after mastectomy doubled between 2004 and 2012, and the combined procedure was associated with higher rates of unplanned readmission, according to data from the National Cancer Data Base.
  • AAD Skin Diseases Affect One in Four Americans Skin problems are common in the United States, especially among the elderly, and will continue to rise as the population ages, new data assessing the incidence and cost show.
  • U.S. Schools Missing Chances to Protect Kids From Sun Most U.S. schools could do a lot more to protect students from the sun, with efforts like keeping kids indoors at high noon or making time for sunscreen application, a recent study suggests.
  • AAD JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.
  • U.S. Sunscreens May Not Meet European Standards While most high-SPF sunscreens in the U.S. meet national standards for ultraviolet A (UVA) protection, about half don’t meet European standards, a recent study found.
  • Mohs and Wide Excision Seem Comparable in Melanoma In patients with melanoma in situ (MIS), Mohs micrographic surgery and wide local excision (WLE) appear to have similar long-term results, according to researchers at the University of California, San Francisco.
  • New Biologic is 'Potential Blockbuster' for Eczema Treatment Dupilumab safely and effectively controls the symptoms of moderate to severe eczema over the long-term, 1-year data show. FDA approval of the biologic is expected soon, the lead investigator reports.
  • New Topical for Mild to Moderate Psoriasis in the Works It's been decades since a new topical option has been available for mild-to-moderate psoriasis, but a new agent shows promise in a phase 3 trial presented as a late-breaker at the AAD Annual Meeting.
  • AAD Low Vitamin D Concerns Lead to Overtesting and Overtreatment Supplements are safe and cheap, while tests can be expensive and inconsistent, experts said. They also addressed controversies around how much vitamin D is necessary and its association with diseases.
  • Tanning Beds Tied to U.S. Health Costs of $343 Million a Year Skin cancers caused by indoor tanning are responsible for $343 million a year in direct medical costs for U.S. patients, a recent study suggests.
  • IL-31 Inhibitor Improves Atopic Dermatitis An interleukin-31 inhibitor significantly improved pruritus for patients whose moderate to severe atopic dermatitis did not respond to topical therapy, a phase 2 clinical trial found.
  • A History of Presidential Healthcare Proposals In consideration of President Trump's first address to Congress this week, we review the history of presidential healthcare proposals, starting with Theodore Roosevelt.
  • Characteristics of Zika Virus Rash Identified
  • Genes Help Predict Male Hair Loss Using data from more than 52,000 men, U.K. researchers have developed a prediction algorithm based entirely on common genetic variants that can discriminate between those with no hair loss and those with severe hair loss.
  • Cempra's Bacterial Skin Infection Drug Succeeds in Key Study Cempra Inc said on Friday that its oral experimental drug to treat acute bacterial skin infections met the main goal of a late-stage study, sending the company's shares surging about 40 percent in premarket trading.
  • AAD Psoriasis Treatments Among Hot Topics at AAD Meeting First-line therapies for moderate to severe psoriasis, the value of vitamin D, and the link between skin disease and problems with other organs will be among the topics covered at the conference.
  • Photodynamic Therapy Useful in Some With Squamous Cell Carcinoma Photodynamic therapy (PDT) along with ablative fractional laser therapy is effective in treating microinvasive squamous cell carcinoma (SCC) when surgery is contraindicated, according to Korean researchers.
  • Gut Microbiome and Response to Anti-PD-1 Immunotherapy for Melanoma The gut microbiome may play a role in response to anti-PD-1 immune checkpoint inhibitor therapy, new research suggests.
  • Mnenomic to Cut False Diagnoses of Recluse Spider Bites A simple mnemonic can help avoid false diagnosis of recluse spider bites, which has been mistaken for up to 40 other medical conditions, according to three U.S. researchers.